Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Drug Daily Bulletin
> FDA Gives Tentative OK to Supernus Pharma’s Tokendi Drug
FDAnews Drug Daily Bulletin
June 27, 2012
| Vol. 9 No. 126
FDA Gives Tentative OK to Supernus Pharma’s Tokendi Drug
Supernus Pharmaceuticals received tentative approval from the U.S. Food and Drug Administration for Tokendi XR, a once-daily extended release formula of topiramate.
The Wall Street Journal
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Pharma Blog Watch
Clinic Becomes Pharma-Free Through Education, Staff Input
GSK to Shut Down Tablet-Packaging Facility in Melbourne
Global Recommendations on Child Medicine